TRELLUS HEALTH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 GBX | 0.00% |
|
-15.56% | -41.54% |
| 24/04 | Transcript : Trellus Health plc, Q4 2023 Earnings Call, Apr 24, 2024 | |
| 23/04 | EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat | AN |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 103.8 | 19.53 |
| Enterprise Value (EV) 1 | 71.81 | 0.4494 |
| P/E ratio | -14.3 x | -2.22 x |
| Yield | - | - |
| Capitalization / Revenue | 4,15,15,87,841 x | 1,08,52,46,251 x |
| EV / Revenue | 2,87,23,07,841 x | 2,49,68,473 x |
| EV / EBITDA | -12.2 x | -0.05 x |
| EV / FCF | -1,14,34,802 x | -54,342 x |
| FCF Yield | -0% | -0% |
| Price to Book | 2.94 x | 0.78 x |
| Nbr of stocks (in thousands) | 1,61,508 | 1,61,508 |
| Reference price 2 | 0.6426 | 0.1210 |
| Announcement Date | 10/05/22 | 26/05/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Net sales | - | 0.025 | 0.018 |
| EBITDA 1 | -1.522 | -5.892 | -8.622 |
| EBIT 1 | -1.524 | -5.902 | -8.687 |
| Operating Margin | - | -23,608% | -48,261.11% |
| Earnings before Tax (EBT) 1 | -1.524 | -5.902 | -8.81 |
| Net income 1 | -1.524 | -5.902 | -8.81 |
| Net margin | - | -23,608% | -48,944.44% |
| EPS 2 | -0.0181 | -0.0448 | -0.0545 |
| Free Cash Flow | - | -6.28 | -8.27 |
| FCF margin | - | -25,119% | -45,946.53% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 01/03/21 | 10/05/22 | 26/05/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Net Debt 1 | - | - | - |
| Net Cash position 1 | 3.68 | 32 | 19.1 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -6.28 | -8.27 |
| ROE (net income / shareholders' equity) | - | -29.9% | -29.2% |
| ROA (Net income/ Total Assets) | - | -17.9% | -17.3% |
| Assets 1 | - | 32.93 | 50.88 |
| Book Value Per Share 2 | 0.0500 | 0.2200 | 0.1600 |
| Cash Flow per Share 2 | 0.0400 | 0.2000 | 0.1200 |
| Capex 1 | 0.02 | 0.08 | - |
| Capex / Sales | - | 324% | - |
| Announcement Date | 01/03/21 | 10/05/22 | 26/05/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -41.54% | 3.83M | |
| +5.80% | 2,935B | |
| +1.64% | 79.66B | |
| +1.50% | 74.71B | |
| -17.06% | 52.02B | |
| +31.33% | 49.26B | |
| -22.83% | 44.97B | |
| +22.46% | 41.74B | |
| +57.98% | 36.02B | |
| -11.11% | 24.35B |
- Stock Market
- Equities
- TRLS Stock
- Financials Trellus Health plc
